642 related articles for article (PubMed ID: 29807101)
21. [Which anti-tumour benefits to be expected from metformin?].
Beck E; Scheen AJ
Ann Endocrinol (Paris); 2013 May; 74(2):137-47. PubMed ID: 23566618
[TBL] [Abstract][Full Text] [Related]
22. Metformin in Oncology - How Far Is Its Repurposing as an Anticancer Drug?
Pácal L; Kaňková K
Klin Onkol; 2020; 33(2):107-113. PubMed ID: 32303131
[TBL] [Abstract][Full Text] [Related]
23. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
24. Metformin in selected malignancies in women.
Markowska A; Stanislawiak-Rudowicz J; Kasprzak T; Markowska J; Szarszewska M
Ginekol Pol; 2022; 93(5):416-421. PubMed ID: 35072253
[TBL] [Abstract][Full Text] [Related]
25. Current understanding of metformin effect on the control of hyperglycemia in diabetes.
An H; He L
J Endocrinol; 2016 Mar; 228(3):R97-106. PubMed ID: 26743209
[TBL] [Abstract][Full Text] [Related]
26. Molecular targets of metformin antitumor action.
Sośnicki S; Kapral M; Węglarz L
Pharmacol Rep; 2016 Oct; 68(5):918-25. PubMed ID: 27362768
[TBL] [Abstract][Full Text] [Related]
27. The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms.
Wiernsperger NF; Bailey CJ
Drugs; 1999; 58 Suppl 1():31-9; discussion 75-82. PubMed ID: 10576523
[TBL] [Abstract][Full Text] [Related]
28. Metformin: a biguanide.
Tanja JJ; Langlass TM
Diabetes Educ; 1995; 21(6):509-10, 513-4. PubMed ID: 8549253
[TBL] [Abstract][Full Text] [Related]
29. Metformin and cancer.
Rizos CV; Elisaf MS
Eur J Pharmacol; 2013 Apr; 705(1-3):96-108. PubMed ID: 23499688
[TBL] [Abstract][Full Text] [Related]
30. Exploring the role of metformin in anticancer treatments: a systematic review.
Miranda VC; Barroso-Sousa R; Glasberg J; Riechelmann RP
Drugs Today (Barc); 2014 Sep; 50(9):623-40. PubMed ID: 25313369
[TBL] [Abstract][Full Text] [Related]
31. Metformin improves atypical protein kinase C activation by insulin and phosphatidylinositol-3,4,5-(PO4)3 in muscle of diabetic subjects.
Luna V; Casauban L; Sajan MP; Gomez-Daspet J; Powe JL; Miura A; Rivas J; Standaert ML; Farese RV
Diabetologia; 2006 Feb; 49(2):375-82. PubMed ID: 16395615
[TBL] [Abstract][Full Text] [Related]
32. A reappraisal on metformin.
Adak T; Samadi A; Ünal AZ; Sabuncuoğlu S
Regul Toxicol Pharmacol; 2018 Feb; 92():324-332. PubMed ID: 29291990
[TBL] [Abstract][Full Text] [Related]
33. Metformin: diamonds are forever.
Papanas N; Maltezos E; Mikhailidis DP
Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
[TBL] [Abstract][Full Text] [Related]
34. Pleiotropic effects of metformin: Shaping the microbiome to manage type 2 diabetes and postpone ageing.
Prattichizzo F; Giuliani A; Mensà E; Sabbatinelli J; De Nigris V; Rippo MR; La Sala L; Procopio AD; Olivieri F; Ceriello A
Ageing Res Rev; 2018 Dec; 48():87-98. PubMed ID: 30336272
[TBL] [Abstract][Full Text] [Related]
35. [Medication of the month. Sitagliptin-metformin fixed combination (Janumet)].
Scheen AJ
Rev Med Liege; 2010 Nov; 65(11):648-54. PubMed ID: 21189532
[TBL] [Abstract][Full Text] [Related]
36. The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development.
Gong J; Kelekar G; Shen J; Shen J; Kaur S; Mita M
Target Oncol; 2016 Aug; 11(4):447-67. PubMed ID: 26864078
[TBL] [Abstract][Full Text] [Related]
37. Metformin as an anti-inflammatory agent: a short review.
Kristófi R; Eriksson JW
J Endocrinol; 2021 Sep; 251(2):R11-R22. PubMed ID: 34463292
[TBL] [Abstract][Full Text] [Related]
38. Does use of metformin protect against cancer in Type 2 diabetes mellitus?
Bo S; Benso A; Durazzo M; Ghigo E
J Endocrinol Invest; 2012 Feb; 35(2):231-5. PubMed ID: 22490993
[TBL] [Abstract][Full Text] [Related]
39. Metformin: a new option in cancer treatment.
Belda-Iniesta C; Pernía O; Simó R
Clin Transl Oncol; 2011 Jun; 13(6):363-7. PubMed ID: 21680296
[TBL] [Abstract][Full Text] [Related]
40. Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning.
Gadducci A; Biglia N; Tana R; Cosio S; Gallo M
Crit Rev Oncol Hematol; 2016 Sep; 105():73-83. PubMed ID: 27378194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
